Efavirenz/emtricitabine/tenofovir disoproxil vs Entecavir
National NHS prescribing compared (Prescription Cost Analysis)
Entecavir was dispensed 279.0× as often as Efavirenz/emtricitabine/tenofovir disoproxil in September 2025 — 279 items versus 1 in England.
1items
Efavirenz/emtricitabine/tenofovir disoproxil · September 2025
NHSBSA Prescription Cost Analysis
279items
Entecavir · September 2025
NHSBSA Prescription Cost Analysis
Figure 1. Efavirenz/emtricitabine/tenofovir disoproxil versus Entecavir: national items dispensed by month
▬ Efavirenz/emtricitabine/tenofovir disoproxil · ╌ Entecavir
Source: NHSBSA Prescription Cost Analysis, to September 2025
| Measure | Efavirenz/emtricitabine/tenofovir disoproxil | Entecavir |
|---|---|---|
| Items, September 2025 | 1 | 279 |
| Items, last 12 months | 12 | 3,325 |
| Net ingredient cost, September 2025 | £533 | £138,668 |
See the full profile for Efavirenz/emtricitabine/tenofovir disoproxil or Entecavir.